Close Menu

Takara Bio

Erich Hunziker retires from Roche; Andrei Lyne becomes CFO at Synpromics; Werner Arber becomes president of the Pontifical Academy of Sciences; and More

WaferGen raised $5 million in a private placement through its Malaysian subsidiary; and entered into a $2 million loan agreement with Oxford Finance.

WaferGen BioSystems and the Integrated BioBank of Luxembourg will co-develop molecular signatures for diagnostic research and commercial applications.

The alliance includes a research partnership and a co-development effort. In addition, WaferGen will establish its European Headquarters at the IBBL facilities.

The company will use proceeds for broad commercialization of its recently launched SmartChip Real-Time PCR system, among other things.

In connection with the loan, the firm issued to Oxford Finance Corp. a warrant to purchase 95,368 of the firm's common stock.

Jeremy Berg is stepping down from NIGMS, Timothy Triche is named to Wafergen's scientific advisory board, and Uwe Neue has died.

WaferGen names Timothy Triche to SAB; Bernd Brust to head Life Tech's Molecular Medicine business.

USC, which was an early-access customer for SmartChip prior to its full commercial launch in August, will use the system to discover and validate biomarkers for pancreatic and colorectal cancer.

Takara has licensed non-exclusive rights to the technology for the research market.


Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.